 4D Pharma PLC has unveiled a senior secured credit facility for up to US30mln with Oxford Finance, a specialty finance firm that provides senior debt to life sciences and healthcare services companies. The AIM-listed firm will receive the cash in three tranches: an initial tranche of US12.5mln at closing, with the remaining US7.5mln and US10mln tranches dependent on the achievement of certain milestones. 